• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    Obinutuzumab
    |
    Weekly News Recap #Phispers Obinutuzumab
    FDA agrees to review Moderna’s amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval

    FDA agrees to review Moderna’s amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval

    Last week, the US Food and Drug Administration (FDA) had said it will not review Moderna’s application for its experiment...

    Impressions : 1884

    Bain buys Mitsubishi Tanabe for US$ 3.4 bn, Novartis acquires Anthos for US$ 3.1 bn, FDA okays AbbVie-Pfizer’s new antibiotic

    Bain buys Mitsubishi Tanabe for US$ 3.4 bn, Novartis acquires Anthos for US$ 3.1 bn, FDA okays AbbVie-Pfizer’s new antibiotic

    In this week’s news, Bain Capital acquired Japanese pharma Mitsubishi Tanabe for US$ 3.4 billion. And Novartis acquired B...

    Impressions : 1939

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.